Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Effects of High-Intensity Laser Therapy Combined With Exercise in Patients With Knee Osteoarthritis (HILT-KOA)

1. Juni 2026 aktualisiert von: Ivan Silva-Satlov, Universidad Metropolitana de Ciencias de la Educacion

Effects of High-intensity Laser Therapy on Muscle Strength in People With Knee Osteoarthritis

The goal of this clinical trial was to determine whether high-intensity laser therapy (HILT) combined with exercise improves pain, physical function, and muscle strength in people with knee osteoarthritis.

The main questions the study aimed to answer were:

  • Did HILT combined with exercise lower pain more than sham laser combined with exercise?
  • Did HILT combined with exercise improve physical function more than sham laser combined with exercise?
  • Did HILT combined with exercise improve knee extensor muscle strength more than sham laser combined with exercise?

Researchers compared HILT plus exercise with sham laser plus exercise to determine whether HILT provided additional benefits beyond those achieved with exercise alone.

Participants:

  • Received either HILT or sham laser treatment for four weeks.
  • Participated in a standardized exercise program.
  • Completed assessments of pain, physical function, and muscle strength before and after treatment.

Studienübersicht

Detaillierte Beschreibung

Knee osteoarthritis is a common musculoskeletal condition associated with pain, reduced physical function, and muscle weakness. Exercise therapy is widely recommended as a first-line treatment; however, the additional benefits of high-intensity laser therapy (HILT) remain uncertain. Previous studies have reported improvements in pain and function following HILT, but results have been inconsistent, and its effects on muscle strength have not been fully established.

The purpose of this randomized, participant-blinded, sham-controlled clinical trial was to evaluate the effects of HILT combined with exercise on pain, physical function, and knee extensor muscle strength in people with knee osteoarthritis.

Participants with clinically diagnosed knee osteoarthritis were randomly assigned to one of two groups. The experimental group received HILT combined with a standardized exercise program, while the control group received sham laser treatment combined with the same exercise program. The intervention lasted four weeks and included ten treatment sessions.

Pain intensity, physical function, and knee extensor muscle strength were assessed before and after the intervention using validated clinical outcome measures. The primary objective was to determine whether HILT provides additional benefits beyond those achieved with exercise alone.

The findings of this study may help clarify the role of HILT as an adjunct treatment in rehabilitation programs for people with knee osteoarthritis and contribute to the development of evidence-based clinical recommendations.

Studientyp

Interventionell

Einschreibung (Tatsächlich)

31

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

    • Santiago Metropolitan
      • Santiago, Santiago Metropolitan, Chile, 7760197
        • Departamento de Kinesiología

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

  • Erwachsene
  • Älterer Erwachsener

Akzeptiert gesunde Freiwillige

Nein

Beschreibung

Inclusion Criteria:

  • Clinical diagnosis of knee osteoarthritis.
  • Age between 45 and 77 years.
  • Pain intensity of at least 3 points on the Visual Analogue Scale (VAS).

Exclusion Criteria:

  • Presence of other musculoskeletal conditions affecting the lower limbs.
  • History of lower limb surgery.
  • Tattoos in the laser application area.
  • Recent intra-articular corticosteroid injection.
  • Comorbidities limiting participation in physical exercise, such as chronic obstructive pulmonary disease, stroke, or severe heart failure.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Behandlung
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Single

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: High Intensity Laser Therapy + Exercise
Participants received high-intensity laser therapy (HILT) combined with a standardized exercise program. HILT was delivered using an MLS laser device (MPHI D, ASA Laser, Italy) over four periarticular knee application points during 10 treatment sessions over four weeks. The exercise program included strengthening, flexibility, and balance exercises and was identical to that provided to the sham comparator group.
High-intensity laser therapy (HILT) was delivered using an MLS laser device (MPHI D, ASA Laser, Italy), which combines synchronized 808 nm and 905 nm wavelengths. Treatment was applied to four periarticular knee regions, including the medial and lateral patellar borders, the suprapatellar region, and the medial tibiofemoral joint line. Participants received 10 treatment sessions over four weeks. HILT was administered in combination with a standardized exercise program.
Andere Namen:
  • Photobiomodulation
  • GRIFF
  • MLS Laser Therapy
  • Laser Therapy
The exercise program was performed during each treatment session and included strengthening, flexibility, and balance exercises targeting the lower extremities. Exercises included stationary cycling, hamstring and gastrocnemius stretching, straight-leg raises, knee extensions, heel raises, step-ups, and single-leg balance activities. The program was standardized for both study groups and was delivered over 10 sessions during a four-week period.
Andere Namen:
  • Therapeutische Übung
  • Rehabilitationsübung
  • Exercise Program
  • Physical Therapy exercise
Schein-Komparator: Sham Laser + Exercise
Participants received sham laser treatment combined with the same standardized exercise program used in the experimental group. Sham treatment was delivered using the same laser device and treatment schedule as the active intervention but with subtherapeutic parameters designed to maintain participant blinding. The intervention consisted of 10 treatment sessions over four weeks. The exercise program included strengthening, flexibility, and balance exercises.
The exercise program was performed during each treatment session and included strengthening, flexibility, and balance exercises targeting the lower extremities. Exercises included stationary cycling, hamstring and gastrocnemius stretching, straight-leg raises, knee extensions, heel raises, step-ups, and single-leg balance activities. The program was standardized for both study groups and was delivered over 10 sessions during a four-week period.
Andere Namen:
  • Therapeutische Übung
  • Rehabilitationsübung
  • Exercise Program
  • Physical Therapy exercise
Sham laser treatment was delivered using the same laser device, treatment schedule, and application sites as the active intervention. Subtherapeutic parameters were used to mimic the treatment procedure while minimizing biological effects and maintaining participant blinding. Participants received 10 treatment sessions over four weeks in combination with the same standardized exercise program used in the experimental group.
Andere Namen:
  • Sham Laser Therapy
  • Placebo Laser
  • Sham High Intensity Laser Therapy

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Change From Baseline in Knee Extensor Muscle Strength After 4 Weeks of Treatment
Zeitfenster: Baseline and Week 4
Change in knee extensor muscle strength measured with a dynamometer. Results were expressed in Newtons (N). Higher values indicate greater muscle strength.
Baseline and Week 4

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Change From Baseline in Pain Intensity After 4 Weeks of Treatment
Zeitfenster: Baseline and Week 4
Change in pain intensity measured using the Visual Analogue Scale (VAS). Scores range from 0 to 10, with higher scores indicating greater pain intensity.
Baseline and Week 4
Change From Baseline in WOMAC Total Score After 4 Weeks of Treatment
Zeitfenster: Baseline and Week 4
Change in symptoms and functional status measured using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Higher scores indicate greater impairment.
Baseline and Week 4

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Ermittler

  • Hauptermittler: Ivan Patricio Silva-Satlov, Magister, Universidad Metropolitana de Ciencias de la Educación

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

29. November 2023

Primärer Abschluss (Tatsächlich)

26. August 2025

Studienabschluss (Tatsächlich)

26. August 2025

Studienanmeldedaten

Zuerst eingereicht

1. Juni 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

1. Juni 2026

Zuerst gepostet (Tatsächlich)

5. Juni 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

5. Juni 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

1. Juni 2026

Zuletzt verifiziert

1. Juni 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

JA

Beschreibung des IPD-Plans

De-identified individual participant data underlying the results reported in publications arising from this study will be available upon reasonable request. Data that support the primary and secondary outcome analyses, including pain, functional status, and muscle strength measurements, may be shared after publication of the primary study results. Requests will be evaluated by the Principal Investigator and must include a scientifically sound research proposal. All shared data will be fully de-identified to protect participant confidentiality.

IPD-Sharing-Zeitrahmen

Individual participant data and supporting documents will be available beginning 6 months after publication of the primary study results and will remain available for 5 years thereafter.

IPD-Sharing-Zugriffskriterien

Researchers who provide a methodologically sound research proposal may request access to de-identified individual participant data and supporting documents. Requests should be directed to the Principal Investigator. Data will be shared only after review and approval of the proposed use and may require a data sharing agreement to protect participant confidentiality and ensure appropriate use of the data.

Art der unterstützenden IPD-Freigabeinformationen

  • STUDIENPROTOKOLL
  • SAFT
  • ICF

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Klinische Studien zur Osteoarthritis (OA) des Knies

Klinische Studien zur High Intensity Laser Therapy

Abonnieren